Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02118909 · ClinicalTrials.gov registry record · Phase 1
Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Subjects
A Phase 1 study, sponsored by Helsinn Healthcare.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT02118909 is a Phase 1 study that has completed, run by Helsinn Healthcare. The registered enrollment target is 32 participants.
The verdict
NCT02118909, a Phase 1 study, has completed, sponsored by Helsinn Healthcare.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study is designed as a 2-part, open-label study to assess the effect of pracinostat with itraconazole (part 1) and pracinostat with ciprofloxacin (part 2) on the bioavailability of pracinostat. Secondarily to evaluate the safety and tolerability of pracinostat administered with itraconazole or ciprofloxacin.
Interventions
- DRUG Itraconazole
- DRUG Ciprofloxacin
- DRUG Pracinostat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2014-05 |
| Est. Completion | 2014-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02118909
The ClinicalTrials.gov registry entry for NCT02118909 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Helsinn Healthcare, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Itraconazole is the first listed.
NCT02118909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02118909 about?
NCT02118909 is a clinical study titled "Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Subjects". This study is designed as a 2-part, open-label study to assess the effect of pracinostat with itraconazole (part 1) and pracinostat with ciprofloxacin (part 2) on the bioavailability of pracinostat. Secondarily to evaluate the safety and tolerability of pracinostat administered with itraconazole or ...
What is the current status of trial NCT02118909?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2014-05. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02118909?
The interventions under investigation include: Itraconazole (DRUG), Ciprofloxacin (DRUG), Pracinostat (DRUG).
Who is sponsoring clinical trial NCT02118909?
This trial is sponsored by Helsinn Healthcare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.